|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||1.2300 - 1.2300|
|52 Week Range||0.8100 - 3.7000|
|Beta (3Y Monthly)||-1.55|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
DENVER, CO / ACCESSWIRE / August 14, 2019 / AmeriCann, Inc. (ACAN), a cannabis company that is developing state-of-the-art cultivation, processing and product manufacturing facilities, recently received a Certificate of Occupancy for Building 1 of AmeriCann’s Massachusetts Cannabis Center (MCC) in Freetown, Mass. The construction milestone commences the 15-year JV Partnership with Bask, Inc., an existing Massachusetts licensed vertically-integrated cannabis operator, which will occupy 100% of MCC’s Building 1 as of September 1, 2019. Previously, AmeriCann and Bask had signed a 15-year Joint Venture Partnership for Bask to operate the 30,000-square-foot greenhouse facility.
DENVER, CO / ACCESSWIRE / August 8, 2019 / AmeriCann, Inc. (ACAN), a cannabis company that is developing state-of-the-art cultivation, processing and product manufacturing facilities, recently secured a $4,000,000 investment to accelerate the second phase of construction at its Massachusetts Cannabis Center (MCC) in Freetown, Mass. The company also announced plans to expand its operations at MCC by applying for a cultivation license in addition to a marijuana product manufacturing license. On August 2, AmeriCann closed on a $4,000,000 loan with proceeds to be used for the final design and site preparation for Building 2 at the MCC. The new configuration of Building 2 includes over 345,000 in total, with 100,000 square feet of dedicated cannabis extraction, processing and product manufacturing space and 245,000 sq. ft. of cultivation infrastructure.
DENVER, CO / ACCESSWIRE / July 22, 2019 / AmeriCann, Inc. (OTCQB: ACAN), a cannabis company that is developing state-of-the-art cultivation, processing and manufacturing facilities, commented on the upcoming hearing on the SAFE Banking Act and the positive outlook for federal cannabis legislation. Sponsored by a bi-partisan group of 31 Senators, the SAFE Banking Act would give cannabis businesses, operating in states where cannabis is legal, access to banking and financial services. The hearing is scheduled for July 23 with Democratic Senator Jeff Merkley (D-OR), Senator Cory Gardner (R-CO) and representatives from the financial and cannabis industries scheduled to testify.
DENVER, CO / ACCESSWIRE / July 9, 2019 / AmeriCann, Inc. (ACAN), a cannabis company that is developing state-of-the-art cultivation, processing and product manufacturing facilities, provided a construction update on Building 1 of its Massachusetts Cannabis Center (MCC). The construction of Building 1 of the MCC, a 30,000 square foot cultivation and processing facility, is 90 percent complete. AmeriCann expects to receive a final Certificate of Occupancy for Building 1 later this summer.
DENVER, CO / ACCESSWIRE / June 6, 2019 / AmeriCann, Inc. (OTCQB: ACAN), a cannabis company that is developing state-of-the-art cultivation, processing and product manufacturing facilities, provided a construction update on Building 1 of the Massachusetts Cannabis Center (MCC). The construction of Building 1 of the MCC, a 30,000 square foot cultivation and processing facility, is more than 80 percent complete. All permanent utilities have been connected, the building's exterior and greenhouse are finished, the interior construction is nearing completion and crews are installing the epoxy flooring for all laboratory spaces.
You may find it surprising, but the Post Office, the Atlanta Hawks and these seven marijuana stocks all have something in common. At first glance, you may think they have nothing to do with each other. After all, the Post Office is run by the government, the Atlanta Hawks are a professional basketball team and cannabis companies were established to profit off of the booming legal cannabis industry.But unfortunately, these very different organizations do in fact have something in common. And it just so happens that it is a very important thing. They are all losing money! None of them have made a profit in years!Obviously, the Post Office can continue to lose money forever because it's run by the governmental and the government can just raise taxes. And a professional sports team can continue to lose money as long as the owners are willing to sustain the losses.InvestorPlace - Stock Market News, Stock Advice & Trading TipsBut let's talk about the cannabis companies In the stock market, the idea is to invest in companies that are, or will be, profitable. This profitability will, in turn, lead to the share price appreciating. Financial theory, history and common sense all tell us that if a company doesn't make money it will eventually go out of business. Investors will see declining share prices and losses.Looking at the Cannabis Companies: You are probably familiar with the following companies if you trade or invest in the cannabis markets. They may have cool products and be in a cool industry, but if you are considering investing in them, it is important to understand that they are losing money. You may ask yourself, "how have they been able to lose money for a sustained period of time?"The answer is that they borrow money or issue stock and use these proceeds to cover their expenses. But eventually, the ability to do so will stop if they are never able to turn a profit. * 7 Strong Buy Stocks That Tick All the Boxes I am not saying that these companies will never earn money and that you can't profit by investing in their stocks. Some of them may eventually become great investments. My intent here is to express my belief that before making an investment in a company, one should consider if it is actually making money and what the future prospects of profitability are. In the long run, these dynamics will ultimately have a significant effect on the share price. Axim Biotechnologies (AXIM) Click to Enlarge Axim Biotechnologies (OTCMKTS:AXIM) makes a really cool product. It is a biotechnology company based in New York City. The company makes chewing gum that is infused with medicinal cannabis. This is used to treat pain, anxiety and other conditions. It can even be used to treat opioid addiction, which we all know is a terrible epidemic. I am not really sure how they do it because I'm a stock market guy, not a scientist, but I think it sounds like an awesome idea.But let's take a look at some numbers. Last year AXIM lost 12 cents per share. That means that for the year the company lost about $6.7 million. Unfortunately, losing money is nothing new to this company. In 2017 they lost $4.2 million, in 2016 the loss was $7.3 million, and it 2015 it was just over $10 million.Not surprisingly, the stock has not acted well. It is currently trading around the $1.50 level. As you can see on the chart, over the past year it has lost about 70% of its value. Maybe someday one of the company's product will be a huge success and it will become profitable, but over the past few years, it has certainly been a disappointment to shareholders. Americann (ACAN) Click to Enlarge Americann, Inc. (OTCMKTS:ACAN) is next on the list. Like many other cannabis companies, they are based in Denver. This company develops medical cannabis cultivation and processing properties. In other words, they build greenhouses. The greenhouses they build aren't like the kind my grandfather had in his garden. These are big-time greenhouses that are used for largescale industrial growing. They have built and developed over one million square feet of growing area.Americann has been involved with some enormous projects. Some of the projects include the Denver Medical Cannabis Center, the Massachusetts Medical Cannabis Center and the Illinois Medical Cannabis Center. The company is also committed to sustainability and uses clean energy from solar and geothermal sources. * 7 Stocks to Buy From the T. Rowe Price Health Sciences Fund Apparently, the Cannabis greenhouse business isn't very profitable -- at least in the way that Americann does it. Last year they lost $4.4 million which equates to a loss of 22 cents per share. This is more than they lost in the prior few years. In 2017 the loss was $2.7 million, in 2016 it was $2.2 million, and in 2015 the loss was $1.7 million. Maybe one day the company will be profitable but, as for now, they seem to be headed in the wrong direction. General Cannabis Corp. (CANN) Click to Enlarge General Cannabis Corp. (OTCMKTS:CANN) is a holding company that is based in Denver. They have four different segments -- security, operations, consumer goods and investments.The security segment provides different types of services to cannabis growers and retails stores. These services include video surveillance, transporting cash and providing security professionals. Consulting services to the cannabis industry that include obtaining licenses, compliance, logistics, retail operations and facility services are offered by the operations segment. The consumer goods segment includes developing relationships with apparel retailers and distributors. The investments segment provides loans and financing to companies within the cannabis industry.General cannabis is clearly an organization that is involved in many things. Maybe it is involved in too many things. Have you ever heard the expression "jack of all trades and master of none?" I think that could apply here. This company hasn't earned any money in years. Last year it lost almost $17 million, or 49 cents per share. The prior year's losses were less than half of that. In 2017, the loss was just over $8 million. In 2016, General cannabis lost just over $10 million and, in 2015, the loss was almost $9 million. If you're keeping track, this company has lost a total of $44 million in the past four years. Cannabis Sativa (CBDS) Click to Enlarge Cannabis Sativa, Inc. (OTCMKTS:CBDS) is next up on the list of losers. After looking at the company website for a while, I couldn't even figure out just what they actually do. I think it has something to do with providing services to cannabis dispensaries. Here is the description from MarketWatch:"Cannabis Sativa, Inc. engages in the research, development, acquisition and licensing of specialized natural cannabis related products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems. The company was founded on November 5, 2005 and is headquartered in Mesquite, NV."This company seems very mysterious to me. According to MarketWatch, there is only one employee despite having revenues that were over $500 million. One of the things that I noticed when I was looking at the financials is that the Quick Ratio is only 0.25 while the average Quick Ratio for the industry is 2.67.The Quick Ratio is the company's cash and short-term securities divided by the current liabilities. Current typically means one year or less. In other words, Cannabis Sativa only has 25 cents for each dollar of debt that they have, while the industry average is to have $2.61 for each $1 of debt. With a ratio like that, it isn't surprising that they are losing money. * 7 Energy Stocks to Buy to Light Up Your Portfolio The losses were $4.1 million in 2018, $7.6 million in 2017, $3.1 million in 2016, and $9.4 million in 2015. Tilray (TLRY) Click to Enlarge Tilray Inc. (NASDAQ:TLRY) hasn't been a publicly traded company for that long. The initial public offering was last summer. This company has the distinction of being the first publicly traded cannabis company to list on the Nasdaq. Their business model is very understandable. They engage in research, cultivation, production, and distribution of cannabis and cannabinoids. Products include dried cannabis and cannabis extracts. In other words, they grow and sell weed.Like the others, this company is losing money as well. I have heard that the cannabis markets are glutted and that the price of cannabis has fallen dramatically since its legalization. Many cannabis farmers are losing a lot of money. Maybe that is why Tilray is losing money as well.Tilray went public last year, but they have disclosed financial information going back further. If you think about it, it is kind of amazing that a company that loses money could go public. This was a common occurrence back in the dot-com era. The company has a market capitalization of around $5 billion despite the fact that they lost $67 million last year. In 2017, they lost about $8 million and had a similar size loss in 2016. 22nd Century Group (XXII) Click to Enlarge 22nd Century Group, Inc. (OTCMKTS:XXII) is based in Clarence, New York. It is a biotech company. They research and develop technologies that will allow the increase or decrease of the levels of nicotine and nicotinic alkaloids in tobacco plants and the levels of cannabinoids in cannabis plants. My guess is that there will be greater demand for increasing than decreasing. This is done through genetic engineering and plant breeding. Sounds like pretty neat stuff.But don't let their cool name and cool stock symbol fool you. They are losing money. Last year the loss was $10.4 million. That is a loss of 8 cents per share. In 2017, the annual loss was close to $17 million. The loss in 2016 was just over $15 million and the loss in 2015 was just over $14 million. * 7 Stocks Worth Buying When They're Down Maybe this company will turn around one day and become successful, but the current shareholders must be disappointed. The valuation has fallen by about one-third since December as the price per share has fallen from $3 to $2 while the broader equity markets have been booming since then. The Supreme Cannabis Co (SPRWF) Click to Enlarge The Supreme Cannabis Co, Inc. (OTCMKTS:SPRWF) is last on the list. Obviously, there are many other cannabis companies that are losing money out there, but today I just wanted to focus on these seven because they seem to be popular recently. Supreme has a similar business model as Tilray. The company grows and sells cannabis, although the product may be a little different because they say it is '"sun-grown." I suppose this is in contrast to being grown with artificial light. Supreme does this through their wholly owned subsidiary 7ACRES.Perhaps The Supreme Cannabis Company should consider changing their name to "The Subprime Cannabis Company" because it is losing money. It has seen the price of its stock fall by about 20% since September. Last year the company lost around $7.3 million. Losses in 2017 were more than twice that at $15.3 million. The loss in 2016 was $4.4 million and the loss in 2015 was about $5.7 million. Maybe the future will be better, but my guess is that The Supreme Cannabis Company's shareholders are supremely disappointed.As of this writing, Mark Putrino did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Energy Stocks to Buy to Light Up Your Portfolio * 10 Vice Stocks to Spice Up Your Portfolio * 7 of the Best ETFs to Buy for a Slowing Economy Compare Brokers The post 7 Marijuana Stocks That Are Bleeding Cash appeared first on InvestorPlace.
DENVER, CO / ACCESSWIRE / April 30, 2019 / AmeriCann, Inc. (OTCQB: ACAN), a cannabis company that is developing state-of-the-art cultivation, processing and product manufacturing facilities, today announced construction is progressing rapidly and on schedule at its flagship project, the Massachusetts Cannabis Center (MCC). The MCC is being developed on a 52-acre parcel located in Southeastern Massachusetts. The MCC project is permitted for 987,000 sq. ft. of cannabis cultivation and processing infrastructure for the existing medical cannabis and the newly emerging adult-use cannabis marketplace.
DENVER, CO / ACCESSWIRE / April 4, 2019 / In an effort to explore how medical cannabis can help veterans, AmeriCann, Inc. (OTCQB: ACAN), a cannabis company that is developing cultivation, processing and manufacturing facilities, announced that it has partnered with the Veterans Health and Cannabis Citizen Science Study in Massachusetts. The research is led by Cannabis Community Care and Research Network (C3RN) and UMass Dartmouth CharltonCollege of Business in collaboration with Veterans Alternative Healing (VAH). The Veterans Health and Cannabis Citizen Science Study seeks to understand veterans' current health status, treatment regimens and medications, current use of cannabis, and issues related to the quality of life, access to insurance options, service history and demographics.
DENVER, CO / ACESSWIRE / March 28, 2019 / AmeriCann, Inc. (OTCQB: ACAN), a cannabis company that is developing state-of-the-art cultivation, processing and product manufacturing facilities, announced Doug Carr will be the new Vice President of Sales and Business Development. Carr will develop strong business alliances and supply chain solutions for AmeriCann's developments throughout the country. Carr will focus initially on the Massachusetts market, developing relationships for AmeriCann Brands, the company's wholly owned consumer packaged goods (CPG) subsidiary.
DENVER, CO / ACCESSWIRE / March 14, 2019 / AmeriCann, Inc. (OTCQB: ACAN), a cannabis company that is developing state-of-the-art cultivation, processing and product manufacturing facilities, today announced the completion of the greenhouse exterior of Building 1 at the Massachusetts Cannabis Center (MCC). AmeriCann's construction of the MCC project has progressed rapidly, and Building 1, a 30,000 square foot cultivation and processing facility, is scheduled for completion in the summer of 2019. AmeriCann uses greenhouse technology, which is superior to the current industry standard of growing cannabis in warehouse facilities under artificial lights.
DENVER, CO / ACCESSWIRE / March 12, 2019 / AmeriCann, Inc. (OTCQB: ACAN ), a cannabis company that is developing state-of-the-art cultivation, processing and product manufacturing facilities, announced ...
Joint Venture will provide Revenue Participation For AmeriCann at Flagship Massachusetts Medical Cannabis Center Building 1 Construction is on Schedule for Completion in Summer 2019 DENVER, CO / ACCESSWIRE ...
DENVER, CO / ACCESSWIRE / February 19, 2019 / AmeriCann, Inc. (OTCQB: ACAN), a cannabis company that is developing cultivation, processing and manufacturing facilities, commented on the impact of newly appointed U.S. Attorney General William Barr and the positive outlook for federal cannabis legislation. "Based on the overwhelming public support for cannabis in the country, it is not a question of if cannabis prohibition at the federal level will end, but rather a matter of when it is repealed," says AmeriCann CEO Tim Keogh.
Construction of the MMCC project is moving forward rapidly, with millions of dollars already invested in site preparation, concrete, and steelwork. The entire building will be 100% leased by an existing, vertically-integrated Massachusetts operator Bask, Inc. The Building 1 project cost is $7,500,000 and is expected to create 30 new direct jobs in the area. The state-of-the-art greenhouse is scheduled to be erected in February adjoining the topped off building, with a completion date for the facility in summer 2019.
DENVER, CO / ACCESSWIRE / January 14, 2019 / AmeriCann, Inc. (OTCQB: ACAN), a cannabis company that is developing state-of-the-art product manufacturing and greenhouse cultivation facilities, announced today that Tim Keogh, CEO, will be a featured presenter at the second annual Benzinga Cannabis Capital Conference to be held in Miami, Florida on Wednesday, January 16. Mr. Keogh will be providing an update on AmeriCann's flagship project the Massachusetts Medical Cannabis Center, the progress of AmeriCann Brands - the Company's extraction and CPG business, and expansion plans as a multi-state operator. AmeriCann's presentation will be at 10:40am in Ballroom 3 at Eden Roc Hotel at 4525 Collins Avenue, Miami Beach, FL.
With the previous presidential administration’s frankness on the matter, marijuana has become more blasé. Naturally, marijuana stocks have also increased in popularity, where we have more choices today than was previously thought possible. For instance, some of the top marijuana stocks are levered toward medical cannabis.
DENVER, CO / ACCESSWIRE / December 18, 2018 / AmeriCann, Inc. (OTCQB: ACAN), a cannabis company that is developing sustainable cultivation, processing and manufacturing facilities provided an update on construction and Adult-Use sales in Massachusetts. AmeriCann has commenced construction on the Massachusetts Medical Cannabis Center (MMCC) on a 52-acre parcel located in Southeastern Massachusetts.
DENVER, CO / ACCESSWIRE / November 29, 2018 / AmeriCann, Inc. (OTCQB: ACAN ), a specialized cannabis company that is developing state-of-the-art product manufacturing and greenhouse cultivation facilities, ...
DENVER, CO / ACCESSWIRE / November 20, 2018 / AmeriCann, Inc. (OTCQB: ACAN), a cannabis company that is developing cultivation, processing and manufacturing facilities announces the commencement of Adult-Use sales in Massachusetts. Adults over 21 years of age now have a safe, legal market to purchase laboratory tested cannabis and cannabis products in Massachusetts. Industry experts believe that the Massachusetts adult-use market, in conjunction with its existing medical program, will exceed $1 billion annually generating hundreds of millions in taxes for the Commonwealth.
DENVER, CO / ACCESSWIRE / November 14, 2018 / AmeriCann, Inc. (OTCQB: ACAN), an agricultural-technology company that is developing the next generation of eco-friendly state-of-the-art greenhouse cannabis cultivation and processing properties, announced today the formation of AmeriCann Brands, Inc. a wholly owned subsidiary for the purpose of obtaining a Consumer Packaged Goods (CPG) manufacturing license in Massachusetts. AmeriCann Brands will manufacture both branded and white-label cannabis products at the Massachusetts Medical Cannabis Center (MMCC) upon the grant of a license.
DENVER, CO / ACCESSWIRE / November 8, 2018 / AmeriCann, Inc. (OTCQB: ACAN), an agricultural-technology company that is developing the next generation of eco-friendly state-of-the-art greenhouse cannabis cultivation and processing properties, today provided commentary on the impact of the recent developments in Washington, D.C. and the outlook for the cannabis industry. U.S. Attorney General Jeff Sessions, an outspoken critic of the cannabis industry, has resigned a day after the Midterm elections. Congressman Pete Sessions was defeated in his re-election bid for Texas' 32nd Congressional District.
Company Plans to Own and Operate Large-Scale Extraction and Product Manufacturing Facility in 2nd Building to Produce Branded Cannabis Beverages, Vaporizer Products, Edible and Non-Edible Products and ...
DENVER, CO / ACCESSWIRE / October 4, 2018 / AmeriCann, Inc. (OTCQB: ACAN), an agricultural-technology company that is developing the next generation of eco-friendly start-of-the-art greenhouse cannabis cultivation and processing properties, has announced plans to own and operate a large-scale cannabis manufacturing and processing facility at its 52-acre Massachusetts Medical Cannabis Center (MMCC) in Freetown, MA. The company has commenced construction on the first phase of the MMCC and recently released designs for the second phase. The second phase includes AmeriCann's manufacturing facility which is designed to provide support to the entire MMCC project, as well as to other licensed cannabis cultivators throughout Massachusetts.
DENVER, CO / ACCESSWIRE / September 21, 2018 / AmeriCann, Inc. (OTCQB: ACAN), an Agricultural-Technology company that is developing state-of-the-art greenhouse cannabis cultivation and processing properties, announced today that CEO Tim Keogh will be speaking at the Cannabis Community Care and Research Network's (C3RN) Cannabis Science and Education Series on Sunday, September 23 in Boston, MA. The event is part of C3RN's monthly Cannabis Science, Education, and Networking series in Massachusetts to showcase the latest cannabis innovations. The events attract diverse groups of leaders from within and outside of the cannabis industry, public health and policy experts and other businesses.
DENVER, CO / ACCESSWIRE / September 12, 2018 / AmeriCann, Inc. (OTCQB: ACAN), an agricultural-technology company that is developing the next generation of eco-friendly start-of-the-art greenhouse cannabis cultivation and processing properties, plans to host a ground breaking celebration for its Massachusetts Medical Cannabis Center (MMCC) on Tuesday, September 25. AmeriCann designed the MMCC on a 52-acre parcel located in Freetown, Mass. The project allows for 987,000 sq. ft. of cannabis cultivation and processing infrastructure and will be developed in three phases. The ground breaking event will celebrate the first phase of the MMCC construction which will be a 30,000 sq. ft. cannabis cultivation, processing and research facility.